English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCRI is proud to announce the appointment of Rachael Brown, Chief Development Officer, and Scott Glenn, Chief Operations Officer.
Tag: Cancer Research Institute
The Cancer Research Institute and the Kidney Cancer Association Announce a Collaboration to Co-Fund Kidney Cancer Immunotherapy Research
The Cancer Research Institute and the Kidney Cancer Association are collaborating on a new kidney cancer immunotherapy research grant.
Cancer Research Institute (CRI) Appoints Alicia Zhou, PhD, as Chief Executive Officer to Advance Next Generation of Cancer Immunotherapy Science and Innovation
The Cancer Research Institute (CRI) has appointed Alicia Zhou, PhD, as its new Chief Executive Officer (CEO).
Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD
CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.
Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations
CRI awarded over $22 million to leading cancer immunotherapy researchers in the 2024 fiscal year, amounting to 64 awards at 42 institutions.
Cancer Research Institute to Honor Dr. Ananda Goldrath with 2023 Alt Award
The Cancer Research Institute is proudly awarding Dr. Ananda Goldrath with the 2023 Fredrick W. Alt award for New Discoveries in Immunology.
The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research
The Cancer Research Institute and the Lustgarten Foundation Announce INSPIRE Partnership to Jointly Support Pancreatic Cancer Immunotherapy Research
Cancer Research Institute Awards Over $28 Million in Grants to Fuel Immunotherapy Innovations
The Cancer Research Institute awarded $28.7 million in research grants and fellowships in the 2023 fiscal year ending June 30, 2023. In total, CRI distributed 73 awards that will advance cancer immunology research at 41 institutions in 10 countries. CRI grants were awarded to support projects involving a variety of immune-based approaches as well as the development of novel technologies that may help pave the way for the next generation of immunotherapies.